EP Patent

EP4637777A1 — Use of estetrol in hepatically impaired patients

Assigned to Estetra SRL · Expires 2025-10-29 · 1y expired

What this patent protects

The present invention relates to a composition comprising an estetrol component for use in alleviating estrogen deficiency symptoms including menopause-associated symptoms in subjects that are characterized by a degree of hepatic impairment. The composition described herein displ…

USPTO Abstract

The present invention relates to a composition comprising an estetrol component for use in alleviating estrogen deficiency symptoms including menopause-associated symptoms in subjects that are characterized by a degree of hepatic impairment. The composition described herein displays favorable pharmacokinetic properties when compared to existing estrogen-based compositions that aim to alleviate estrogen deficiency symptoms. Also described herein are uses related to the above and corresponding methods of treatment.

Drugs covered by this patent

Patent Metadata

Patent number
EP4637777A1
Jurisdiction
EP
Classification
—
Expires
2025-10-29
Drug substance claim
No
Drug product claim
No
Assignee
Estetra SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.